Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00420160 · ClinicalTrials.gov registry record · Phase 2

Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?

A Phase 2 study, sponsored by The Miriam Hospital.

Completed
Registry status
Phase 2
Development phase
59
Enrollment target

NCT00420160 is a Phase 2 study that has completed, run by The Miriam Hospital. The registered enrollment target is 59 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00420160, a Phase 2 study, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
Phase 2
Development phase
59 participants
Enrollment target

Study Summary

This study compares the effects of a standard smoking cessation treatment, including one-time brief counseling and provision of nicotine patch plus an 8-week moderate intensity exercise program versus the same standard smoking cessation treatment plus equivalent contact control among 60 healthy women. We hypothesize that participants in the smoking cessation plus moderate intensity exercise condition will be more likely to quit smoking than participants in the smoking cessation treament plus contact control condition.

Interventions

  • BEHAVIORAL Smoking cessation treatment plus moderate intensity exercise
  • BEHAVIORAL Smoking cessation treatment plus health education

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2007-02
Est. Completion 2008-12
Phase Phase 2

Sponsor

The Miriam Hospital

136 total trials

What the Registry Record Tells You About NCT00420160

The ClinicalTrials.gov registry entry for NCT00420160 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Smoking cessation treatment plus moderate intensity exercise is the first listed.

NCT00420160 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00420160 about?

NCT00420160 is a clinical study titled "Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?". This study compares the effects of a standard smoking cessation treatment, including one-time brief counseling and provision of nicotine patch plus an 8-week moderate intensity exercise program versus the same standard smoking cessation treatment plus equivalent contact control among 60 healthy wome...

What is the current status of trial NCT00420160?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 59 participants. The study started on 2007-02. Estimated completion is 2008-12.

What interventions are being tested in trial NCT00420160?

The interventions under investigation include: Smoking cessation treatment plus moderate intensity exercise (BEHAVIORAL), Smoking cessation treatment plus health education (BEHAVIORAL).

Who is sponsoring clinical trial NCT00420160?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.